Quantcast

Latest Anatomical pathology Stories

2014-07-30 08:32:03

Investment will support scale of global services, development of independent diagnostic tests, and deployment of future companion diagnostic products SAN DIEGO, July 30, 2014 /PRNewswire/ -- Epic Sciences, Inc. ("Epic"), a privately held biotech company that designs and develops novel diagnostics to personalize and advance the treatment and management of cancer, announced today the completion of a $30 million Series C Preferred Stock financing. The financing included new investors...

2014-07-28 23:00:40

Rising incidence of other chronic diseases, aging population, and increasing healthcare spending will aid the growth of the global tissue diagnostics market - http://www.marketsandmarkets.com/Market-Reports/tissue-diagnostics-market-1063949.html. (PRWEB) July 29, 2014 The “Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small...

2014-07-25 10:41:50

Temple University Health System Asking patients if a suspicious skin lesion is painful or itchy may help doctors decide whether the spot is likely to be cancerous, according to a new study headed by Gil Yosipovitch, MD, Chairman of the Department of Dermatology at Temple University School of Medicine. The study, published online by JAMA Dermatology on July 23, 2014, found that nearly 36. 9 percent of skin cancer lesions are accompanied by itching, while 28.2 percent involve pain....

2014-07-24 23:05:03

The first-ever successful isolation and culture of rare tumor cells circulating in a patient’s blood has been achieved by NFCR-supported scientist Daniel Haber, M.D., Ph.D., and his team at Massachusetts General Hospital. Bethesda, MD (PRWEB) July 24, 2014 The first-ever successful isolation and culture of rare tumor cells circulating in a patient’s blood has been achieved by NFCR-supported scientist Daniel Haber, M.D., Ph.D., and his team at Massachusetts General Hospital. This is an...

2014-07-23 23:18:30

Transparency Market Research published a new report "Circulating Tumor Cells (CTCs) Prognostic Technologies Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020" to its report store. Browse the full report: http://www.transparencymarketresearch.com/ctcs-prognostic-technologies-market.html Albany, New York (PRWEB) July 22, 2014 According to a new market report published by Transparency Market Research “Circulating Circulating Tumor Cells (CTCs)...

2014-07-15 23:10:15

Certification designates that the software is capable of supporting eligible providers with meeting the Stage 1 and Stage 2 Meaningful Use measures. Irving, Texas (PRWEB) July 15, 2014 Miraca Life Sciences (MLS), the nation’s largest independent anatomic pathology lab, announced today that its PathConnect system, a web-based pathology workflow automation system, has achieved ONC HIT 2014 Edition Modular Ambulatory EHR certification. This certification designates that the software is...

2014-07-11 10:56:11

Massachusetts General Hospital Circulating tumor cells captured with a microchip-based device developed at the Massachusetts General Hospital (MGH) Center for Engineering in Medicine and the MGH Cancer Center can be cultured to establish cell lines for genetic analysis and drug testing. In the July 11 issue of Science, an MGH research team reports that the cultured cells accurately reflect a tumor's genetic mutation over time and changing susceptibility to therapeutic drugs. "We now...

2014-07-10 12:22:20

Fox Chase Cancer Center Study Finds that Some Women Do Better than Current Staging Guidelines Suggest New findings from Fox Chase Cancer Center paint a relatively optimistic picture of women’s chances of surviving a subset of breast cancers that have spread to the chest wall or skin, but not beyond. Tumors that grow into the skin, regardless of size and whether they have involved lymph nodes, are automatically classified as stage III – and called “locally advanced” tumors,...

2014-07-10 08:27:59

BEVERLY HILLS, Calif., July 10, 2014 /PRNewswire/ -- Dr. Bruce Lee, fibroid surgeon and inventor of the Acessa procedure, has opened his practice in Beverly Hills in conjunction with the Rox Center. Dr. Lee has worked to bring this unique treatment for women by harnessing the power of radiofrequency energy. This allows women to have their fibroids treated with a minimally invasive outpatient procedure that is safe and very effective. This treatment is an alternative to...

2014-07-09 16:25:41

LONDON, July 9, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Ultrasound Devices Market (By Product Type - Cart/Trolley Based Ultrasound Devices and Compact Ultrasound Devices, By Technology and By Application) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019...


Latest Anatomical pathology Reference Libraries

Indian Journal of Dermatology
2012-05-14 15:38:38

The Indian Journal of Dermatology, Venereology and Leprology (IJDVL) is a peer-reviewed open-access medical journal published bimonthly on behalf of the Indian Association of Dermatologists, Venereologists and Leprologists. It was established in 1940 and the current editor-in-chief is D.M. Thappa (as of May 2012). The journal reaches more than 6,000 members of the IADVL as well as nearly 200 medical colleges in India. The journal focuses on articles on clinical and experimental...

45_16476fe85b6c94ca2cddefe0d4dea632
2011-02-17 16:45:25

Merkel cell polyomavirus (MCV or MCPyV), first discovered in January 2008, is one of seven human tumor viruses. It is suspected to cause most of Merkel cell carcinoma which is a rare, aggressive form of skin cancer. Around 80% of Merkel cell carcinoma tumors are found to be infected with MCV. It is found in respiratory secretions suggesting that it may be transmitted by a respiratory route. Usually the tumors with MCV viruses go through at least two mutations that render the virus...

More Articles (2 articles) »
Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related